Gain Therapeutics Q1 2022 Earnings Review

Tuesday, 26 March 2024, 19:26
Gain Therapeutics released its Q1 2022 financial results, reporting a GAAP EPS of -$1.71, missing expectations by $0.14. Additionally, the company's revenue of $0.05M fell short by $0.25M. The results highlight challenges in the company's performance for the quarter, raising concerns among investors.
LivaRava Finance Meta Image
Gain Therapeutics Q1 2022 Earnings Review

Gain Therapeutics Q1 2022 Earnings Review

Gain Therapeutics released its financial report for the first quarter of 2022, revealing a GAAP EPS of -$1.71, missing expectations by $0.14. The company's revenue of $0.05M was also below projections, with a shortfall of $0.25M.

Do you want to advertise here? Contact us

Related posts

Do you want to advertise here? Contact us
Do you want to advertise here? Contact us
Newsletter

We carefully select news from the world of finance and publish it for our users. We understand the importance of reliable and up-to-date information for people in the financial world. Do you want to receive news in a convenient format and always have it at hand — subscribe to our newsletter and make your analytical work more effective.

Subscribe